干扰素驱动的代谢重编程和瘤微环境重塑
Tzu-Hsuan Chang1,2, Ping-Chih Ho1,2
1Department of Fundamental Oncology, University of Lausanne, 1015 Lausanne, Switzerland.
Immune network
|March 13, 2025
概括
干扰子 (IFN) 在癌症中至关重要,重编程瘤新陈代谢并塑造瘤微环境 (TME). 它们影响免疫细胞,调解抗瘤和亲瘤效应,指导未来的癌症疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 干扰素 (IFN) 是癌症生物学的关键调节剂.
- IFN影响瘤细胞行为和瘤微环境 (TME).
- 最近的发现强调了IFN在重编程瘤代谢中的作用.
研究的目的:
- 审查IFN对癌症代谢重编程的影响.
- 总结IFN对TME内的免疫细胞功能的影响.
- 探索IFN在抗瘤和前瘤免疫反应中的双重作用.
主要方法:
- 关于IFN在癌症中的研究的文献评论.
- 对IFN介导的代谢重编程机制的分析.
- 检查IFN对TME免疫细胞透和功能的影响.
主要成果:
- IFN显著改变瘤细胞的新陈代谢.
- 在TME中,IFN调节免疫细胞透和功能.
- IFN具有双重作用,促进抗瘤和前瘤免疫力.
结论:
- IFN是癌症的关键参与者,影响瘤代谢和免疫TME.
- 了解IFN介导的过程对于开发新型癌症疗法至关重要.
- IFN的双重免疫调节功能提供了治疗机会和挑战.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Regulation of Metabolism
9.2K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


